Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma.
Lu D, Lu T, Gibiansky L, Li X, Li C, Agarwal P, Shemesh CS, Shi R, Dere RC, Hirata J, Miles D, Chanu P, Girish S, Jin JY.
Lu D, et al. Among authors: gibiansky l.
CPT Pharmacometrics Syst Pharmacol. 2020 Jan;9(1):48-59. doi: 10.1002/psp4.12482. Epub 2019 Dec 23.
CPT Pharmacometrics Syst Pharmacol. 2020.
PMID: 31749251
Free PMC article.